The Latin America, Middle East and Africa Bioprocess Bags Market would witness market growth of 22.4% CAGR during the forecast period (2023-2029).
The expansion of the market has been significantly aided by the development of technology used in bioprocessing. Utilizing single-use bioreactors, created specifically for use in conjunction with bioprocess bags, is a significant step forward in developing bioprocessing technology. Compared to conventional bioreactors made of stainless steel, these bioreactors are more manageable in size, more adaptable, and simpler to operate. These provide several benefits, including a decreased likelihood of contamination, increased productivity, and decreased expenditures.
Producing cell and gene therapies, which require specific materials and equipment such as bioprocess bags, is another significant step forward in medical research. However, to provide the therapies to patients, the therapies must first be manufactured.
Cell and gene therapies necessitate utilizing specialized manufacturing procedures, most of which call for the application of one-time-use technologies like bioprocess bags. In addition, the production of therapeutic goods using these therapies requires using sterile and regulated settings, and bioprocess bags offer an appropriate solution for storing and transferring the ingredients used in the manufacturing process. In the years to come, the need for bioprocess bags is anticipated to be driven in large part by the expansion of the market for cell and gene therapies.
The prevalence of the coronavirus has heightened awareness of the importance of a flourishing healthcare sector and the function that technology can play in achieving this; the UAE and Dubai are no exception. The biomedical and pharmaceutical companies in the region were crucial to the UAE's response to the pandemic. As a result, the governing body of the United Arab Emirates is exerting significant effort to assist the pharmaceutical industry. The pharmaceutical industry is the focus of activities because of its prospective growth potential, export potential, and medium- to long-term economic impact.
The government is establishing relationships with key international market participants to increase its production of medicinal items. As a result, the pharmaceutical industry in the UAE is anticipated to develop in the coming years due to favorable financing, planned distribution channels, shrewd planning, and a well-established logistical infrastructure. This would promote the utilization of single-use bioprocessing technologies, expanding the regional market.
The Brazil market dominated the LAMEA Bioprocess Bags Market by Country in 2022, thereby, achieving a market value of $187.3 million by 2029. The Argentina market is experiencing a CAGR of 23.1% during (2023 - 2029). Additionally, The UAE market would exhibit a CAGR of 22.1% during (2023 - 2029).
Based on Workflow, the market is segmented into Upstream Process, Downstream Process and Process Development. Based on Type, the market is segmented into 2D, 3D and Others. Based on End-User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs and Academic & Research Institutes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Bioprocess Bags Market is Projected to reach USD 7.8 Billion by 2029, at a CAGR of 16.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation, Saint-Gobain Group, Corning Incorporated, Meissner Filtration Products, Inc., Merck KGaA, Entegris, Inc., PROAnalytics, LLC, and CellBios Healthcare and Lifesciences Pvt Ltd.
By Workflow
By Type
By End-User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
